These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39411170)

  • 1. Analysis of clinicopathological characteristics and prognostic factors in 54 metaplastic breast carcinoma patients from northwest China.
    Du J; Wu S; Liu J; Guo B; Li J; Li W; Zhang Y; Song H; Shu W; Li Z; Zhu X
    Cytojournal; 2024; 21():31. PubMed ID: 39411170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-Negative Metaplastic Breast Carcinoma: Association of Epidermal Growth Factor Receptor Expression With Prognostic Parameters and Clinical Outcome.
    Munawar S; Haider R; Ali SM; Yaqeen SR; Islam S; Asghar IA; Afzal A; Zia S; Irfan M; Hashmi AA
    Cureus; 2021 May; 13(5):e15006. PubMed ID: 34150374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
    El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
    Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center.
    Zhang Y; Lv F; Yang Y; Qian X; Lang R; Fan Y; Liu F; Li Y; Li S; Shen B; Pringle GA; Zhang X; Fu L; Guo X
    PLoS One; 2015; 10(6):e0131409. PubMed ID: 26115045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
    Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
    Yang X; Tang T; Zhou T
    World J Surg Oncol; 2023 Nov; 21(1):364. PubMed ID: 37996840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metaplastic Breast Carcinoma: Clinicopathological Parameters and Prognostic Profile.
    Haroon S; Zia S; Shirazi UA; Ahmed O; Asghar IA; Diwan MA; Afzal A; Irfan M; Ali SJ; Hashmi AA
    Cureus; 2021 Apr; 13(4):e14347. PubMed ID: 33987039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and Radiological Features with Long Term Follow Up of Metaplastic Carcinoma Breast in India.
    Puri G; Lohani KR; Khadka S; Kataria K; Ranjan P; Hari S; Mathur S; Dhar A; Srivastava A
    Asian Pac J Cancer Prev; 2021 Nov; 22(11):3483-3492. PubMed ID: 34837903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast.
    Xiao M; Yang Z; Tang X; Mu L; Cao X; Wang X
    Oncol Lett; 2017 Aug; 14(2):1971-1978. PubMed ID: 28781640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metaplastic carcinoma of the breast: clinicopathological features and immunohistochemical analysis.
    Yilmaz KB; Pak I; Irkkan C; Ozaslan C; Atalay C
    J BUON; 2011; 16(4):652-6. PubMed ID: 22331717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment.
    Aydiner A; Sen F; Tambas M; Ciftci R; Eralp Y; Saip P; Karanlik H; Fayda M; Kucucuk S; Onder S; Yavuz E; Muslumanoglu M; Igci A
    Medicine (Baltimore); 2015 Dec; 94(52):e2341. PubMed ID: 26717372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant Phenotype p53 Immunohistochemical Expression Is Associated With Poor Prognostic Parameters and Disease-Free Survival in Triple-Negative Metaplastic Breast Carcinoma.
    Hashmi AA; Sajid A; Hussain M; Zia S; Islam S; Diwan MA; Ali SM; Irfan M; Shamail F; Zia F
    Cureus; 2021 May; 13(5):e15244. PubMed ID: 34188985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metaplastic breast cancer: clinicopathological features and its prognosis.
    Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J
    J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metaplastic breast carcinoma: a clinical analysis of 26 cases.
    Jin X; Yu D; Guo C; Gong X; Li N; Zhao Y
    Int J Clin Exp Pathol; 2018; 11(4):2112-2117. PubMed ID: 31938320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
    Li Y; Zhang N; Zhang H; Yang Q
    J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better Local Disease Control With Mastectomy in Metaplastic Breast Carcinoma: Findings of a Retrospective Cohort.
    Turhan N; Memişoğlu E; Kökten ŞÇ; Güzel NT; Zarbaliyev E
    Cureus; 2024 Jun; 16(6):e61517. PubMed ID: 38957239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metaplastic Breast Cancer: Characteristics and Survival Outcomes.
    Thapa B; Arobelidze S; Clark BA; Xuefei J; Daw H; Cheng YC; Patel M; Spiro TP; Haddad A
    Cureus; 2022 Aug; 14(8):e28551. PubMed ID: 36185859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.